These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7034644)

  • 1. In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins.
    Cynamon MH; Palmer GS
    Antimicrob Agents Chemother; 1981 Dec; 20(6):841-2. PubMed ID: 7034644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.
    Gutmann L; Goldstein FW; Kitzis MD; Hautefort B; Darmon C; Acar JF
    Antimicrob Agents Chemother; 1983 Feb; 23(2):248-51. PubMed ID: 6340602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin.
    Gombert ME
    Antimicrob Agents Chemother; 1982 Jun; 21(6):1011-2. PubMed ID: 7051971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.
    Cynamon MH; Palmer GS
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1079-81. PubMed ID: 6961887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
    Cynamon MH; Granato PA
    Chemotherapy; 1982; 28(3):204-8. PubMed ID: 6212205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides.
    Gombert ME; Aulicino TM
    Antimicrob Agents Chemother; 1983 Nov; 24(5):810-1. PubMed ID: 6362558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
    O'Donnell ED; Freimer EH; Gilardi GL; Raeder R
    Antimicrob Agents Chemother; 1982 Apr; 21(4):673-5. PubMed ID: 6211143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
    Corrado ML; Landesman SH; Cherubin CE
    Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
    Gutiérrez-Núñez J; Harrington PT; Ramirez-Ronda CH
    Antimicrob Agents Chemother; 1982 Mar; 21(3):509-12. PubMed ID: 6954876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Nocardia asteroides to new quinolones and beta-lactams.
    Gombert ME; Aulicino TM; duBouchet L; Berkowitz LR
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2013-4. PubMed ID: 3326528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
    Cherubin CE; Corrado ML; Sierra MF; Gombert ME; Shulman M
    Antimicrob Agents Chemother; 1981 Oct; 20(4):553-5. PubMed ID: 6282200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
    Brown JE; Del Bene VE; Collins CD
    Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):402-6. PubMed ID: 6264844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I; Machka K; Elsser R
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.
    Ahonkhai VI; Cherubin CE; Sierra MF; Bokkenheuser VD; Shulman MA; Mosenthal AC
    Antimicrob Agents Chemother; 1981 Dec; 20(6):850-1. PubMed ID: 6459767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Miller MA; LeFrock JL; Vercler MJ
    Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Hanslo D; King A; Shannon K; Warren C; Phillips I
    J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents.
    Dewsnup DH; Wright DN
    Antimicrob Agents Chemother; 1984 Feb; 25(2):165-7. PubMed ID: 6370125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
    Owens WE; Finegold SM
    Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.
    Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
    Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.